IL125522A0 - Methods of increasing sphincter competence - Google Patents

Methods of increasing sphincter competence

Info

Publication number
IL125522A0
IL125522A0 IL12552297A IL12552297A IL125522A0 IL 125522 A0 IL125522 A0 IL 125522A0 IL 12552297 A IL12552297 A IL 12552297A IL 12552297 A IL12552297 A IL 12552297A IL 125522 A0 IL125522 A0 IL 125522A0
Authority
IL
Israel
Prior art keywords
methods
sphincter competence
increasing sphincter
increasing
competence
Prior art date
Application number
IL12552297A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603147.1A external-priority patent/GB9603147D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL125522A0 publication Critical patent/IL125522A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12552297A 1996-01-29 1997-01-27 Methods of increasing sphincter competence IL125522A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1077196P 1996-01-29 1996-01-29
GBGB9603147.1A GB9603147D0 (en) 1996-02-15 1996-02-15 Methods of increasing sphincter competence
PCT/US1997/001159 WO1997026876A1 (en) 1996-01-29 1997-01-27 Methods of increasing sphincter competence

Publications (1)

Publication Number Publication Date
IL125522A0 true IL125522A0 (en) 1999-03-12

Family

ID=26308706

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12552297A IL125522A0 (en) 1996-01-29 1997-01-27 Methods of increasing sphincter competence

Country Status (11)

Country Link
EP (1) EP0910378A4 (cs)
JP (1) JP2000503991A (cs)
CN (1) CN1213303A (cs)
AU (1) AU732473B2 (cs)
CZ (1) CZ235598A3 (cs)
EA (1) EA001103B1 (cs)
HU (1) HUP9903440A3 (cs)
IL (1) IL125522A0 (cs)
NO (1) NO983453L (cs)
NZ (1) NZ331085A (cs)
WO (1) WO1997026876A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1113007A1 (en) 1999-12-24 2001-07-04 Pfizer Inc. Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
AU2001271781A1 (en) * 2000-07-06 2002-01-21 Wyeth Use of substituted indole compounds for treating sphincter incontinence
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
US20040248989A1 (en) * 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
ES2551690T3 (es) 2006-05-22 2015-11-23 Hormos Medical Ltd. Método de tratamiento de la prostatitis crónica no bacteriana con moduladores selectivos del receptor de estrógeno o inhibidores de aromatasa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
US5492927A (en) * 1993-12-21 1996-02-20 Eli Lilly And Company Non-peptide tachykinin receptor antagonists to treat allergy
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
AU3899595A (en) * 1994-12-02 1996-06-19 Mostyn Farmer Golf stance training aid
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents

Also Published As

Publication number Publication date
EA199800676A1 (ru) 1999-02-25
EA001103B1 (ru) 2000-10-30
EP0910378A1 (en) 1999-04-28
WO1997026876A1 (en) 1997-07-31
CN1213303A (zh) 1999-04-07
HUP9903440A2 (hu) 2000-06-28
CZ235598A3 (cs) 1999-03-17
AU1838697A (en) 1997-08-20
NZ331085A (en) 2000-06-23
JP2000503991A (ja) 2000-04-04
EP0910378A4 (en) 1999-06-23
AU732473B2 (en) 2001-04-26
HUP9903440A3 (en) 2000-07-28
NO983453L (no) 1998-09-11
NO983453D0 (no) 1998-07-27

Similar Documents

Publication Publication Date Title
PL330990A1 (en) Improved method of halogenating isomo-olefinic copolymers
PL331771A1 (en) Method of improving seeds
PL333364A1 (en) Novel compounds and method of using them
IL125829A0 (en) Method of sharing cryptokey
EP0914115A4 (en) NEUROPROTECTION METHODS
PL318452A1 (en) Method of obtaining peroxyperfluoropolyoxyalkylenes
EP1017459A4 (en) GAME OF CHANCE
PL330400A1 (en) Method of obtaining azacyclohexapeptides
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
IL125522A0 (en) Methods of increasing sphincter competence
PL332077A1 (en) Method of obtaining omepraole
GB9602704D0 (en) Structure of perculator
CY2590B2 (en) Preparation of 1-butyl-4-piperidinylmethylamine
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
PL313419A1 (en) Method of obtaining beta-naphtole
PL333977A1 (en) Method of obtaining benzisothiazolyn-3-ones
PL321479A1 (en) Method of polymerising isocyanatges
PL328082A1 (en) Method of improving sphincter competence
GB9603147D0 (en) Methods of increasing sphincter competence
GB9616563D0 (en) Compounds and methods
GB2317119B (en) Educational system of shapes
PL332075A1 (en) Method of obtaining nizathidine
PL317788A1 (en) Method of obtaining 3-isocyanate-propylsilane
EP0934345A4 (en) CONNECTIONS AND PROCEDURE
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides